LOADING
Comparing Walmart Inc (WMT) and Pfizer Inc (PFE) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | WMT | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $1.04T | $152.4B |
| P/E Ratio | 47.6 | 19.7 |
| Forward P/E | 43.9 | 9.3 |
| PEG Ratio | 4.85 | 13.77 |
| EPS | $2.73 | $1.36 |
| Revenue Growth (YoY) | 5.6% | -1.2% |
| Profit Margin | 3.1% | 12.4% |
| Return on Equity | 21.8% | 8.9% |
| Dividend Yield | 0.73% | 6.30% |
| Beta | 0.66 | 0.39 |
| 52-Week High | $134.41 | $28.75 |
| 52-Week Low | $91.30 | $20.87 |
| Volume | -- | -- |
Walmart Inc is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.